BookmarkSubscribeRSS Feed
satish123
Fluorite | Level 6

Dear all,

As we know for NTI drugs guidelines http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm201283.pdf has suggested that use both (1)scaled and unscaled ABE, in addition to that (2)calculation of 90% CI of ratio of within subject standard deviation of test to reference product.

here my problem is (2). i don't know how to calculate (2). but i tried it with 'COVPRMS' of 'PROC MIXED' from normal ln transformed data (not from ilat, dlat). i calculated within subject standard deviation for test and reference using 'estimates' in 'COVPRMS'. now i just want to know am i doing it in the correct way or not?

Thanks and Regards,

Satish.

sas-innovate-2024.png

Don't miss out on SAS Innovate - Register now for the FREE Livestream!

Can't make it to Vegas? No problem! Watch our general sessions LIVE or on-demand starting April 17th. Hear from SAS execs, best-selling author Adam Grant, Hot Ones host Sean Evans, top tech journalist Kara Swisher, AI expert Cassie Kozyrkov, and the mind-blowing dance crew iLuminate! Plus, get access to over 20 breakout sessions.

 

Register now!

New Learning Events in April

 

Join us for two new fee-based courses: Administrative Healthcare Data and SAS via Live Web Monday-Thursday, April 24-27 from 1:00 to 4:30 PM ET each day. And Administrative Healthcare Data and SAS: Hands-On Programming Workshop via Live Web on Friday, April 28 from 9:00 AM to 5:00 PM ET.

LEARN MORE

Discussion stats
  • 0 replies
  • 1424 views
  • 0 likes
  • 1 in conversation